We recently demonstrated that MSCs can suppress mononuclear cell proliferation and reduce the severity of colitis in mice by producing PGE2 via the nucleotide-binding oligomerization domain 2 (NOD2)-receptor-interacting serine/threonine-protein kinase 2 (RIP2) pathway [14]. This evidence concerns the gene RIPK2 and colitis.